Phaarmasia Limited (BOM:523620)
India · Delayed Price · Currency is INR 81.86
-0.41 (-0.50%)
At close: Mar 4, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 558.85 million as of March 5, 2026. Its market cap has increased by 81.11% in one year.
Market Cap
558.85M
Enterprise Value
554.55M
Revenue
449.06M
Ranking
n/a
PE Ratio
3.15
Stock Price
81.86
Market Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 558.85M, an increase of 3,978.58%. That is a compound annual growth rate of 14.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 558.85M | -27.39% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Accretion Pharmaceuticals | 756.44M |
| Asston Pharmaceuticals | 681.04M |
| Amwill Health Care | 669.12M |
| Onyx Biotec | 612.87M |
| Godavari Drugs | 585.20M |
| Shelter Pharma | 540.78M |
| Biofil Chemicals and Pharmaceuticals | 494.72M |
| Mangalam Drugs & Organics | 442.87M |